[en] Adjuvants, Immunologic/pharmacology/therapeutic use ; Aminoquinolines/pharmacology/therapeutic use ; Cytokines/secretion ; Humans ; Macrophages/immunology ; Skin Diseases/drug therapy/immunology
[en] Imiquimod is the first drug of a new therapeutic class encompassing cutaneous immune response modifiers. This molecule induces the synthesis and release of macrophage-related cytokines. It boosts some local immune responses. These properties are used to treat cutaneous viral condylomas. Other prospective therapeutic goals are presently scrutinized.